Molecular endocrinology of sex differentiation

Seminars in Reproductive Medicine

Volumn 20, Issue 3, 2002, Pages 169-179

  Warne, Garry L ^a   Kanumakala, Shankar ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Ambiguous genitalia; M llerian duct; Sex differentiation; Sex reversal; Wolffian duct

Indexed keywords

17 HYDROXYPREGNENOLONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; AROMATASE; CHOLESTEROL; CYTOCHROME P450C17; ESTRADIOL; ESTROGEN; ESTRONE; HYDROXYPROGESTERONE; PRASTERONE; PREGNENOLONE; PROGESTERONE; TESTOSTERONE;

ANDROGEN RELEASE; DIAGNOSTIC APPROACH ROUTE; EMBRYONIC STRUCTURES; ENDOCRINOLOGY; FEMALE; FETUS; GENETIC ANALYSIS; GENITAL SYSTEM; HUMAN; MALE; MOLECULAR BIOLOGY; MUELLERIAN DUCT; OVARY; PROCESS MODEL; REVIEW; SEX DIFFERENTIATION; SEX DIFFERENTIATION DISORDER; SEX TRANSFORMATION; TESTIS; UROGENITAL SINUS;

ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; GENITALIA; HORMONES; HUMANS; SEX DIFFERENTIATION;

EID: 0036669347     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35381     Document Type: Review

References (28)

1. Segaloff DL, Ascoli M. The lutropin/chorionic gonadotropin receptor: 4 Years later. Endocr Rev 1993;14:324-347
2. de Roux N, Milgrom E. Inherited disorders of GnRH and gonadotropin receptors. Mol Cell Endocrinol 2001;179:83-87
3. Aittomaki K, Hreva R, Stenman U-H, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996;81:3722-3726
4. Boehmer AL, Brinkmann AO, Sandkuijl LA, et al. 17Beta-hydroxysteroid dehydrogenase-3 deficiency: Diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999;84:4713-4721
5. Shaw G, Renfree MB, Leihy MW, et al. Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol. Proc Natl Acad Sci U S A 2000;97:12256-12259
6. Chetyrkin SV, Hu J, Gough WH, Dumaual N, Kedishvili NY. Further characterization of human microsomal 3alpha-hydroxysteroid dehydrogenase. Arch Biochem Biophys 2001;386:1-10
7. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: Placental aromatase deficiency. J Clin Endocrinol Metab 1991;72:560-566
8. Grumbach MM, Auchus RJ. Estrogen: Consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999;84:4677-4694
9. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of the CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186
10. Bratt O, Borg A, Kristoffersson U, et al. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br J Cancer 1999;81:672-676
11. Ishii T, Sato S, Kosaki K, et al. Micropenis and the AR gene: Mutation and CAG repeat-length analysis. J Clin Endocrinol Metab 2001;86:5372-5378
12. Lobaccaro JM, Lumbroso S, Poujol N, Belon C, Sultan C. Molecular genetics of androgen insensitivity syndromes. Cell Mol Biol 1994;40:301-308
13. Boehmer AL, Bruggenwirth H, van Assendelft C, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 2001;86:4151-4160
14. Josso N, di Clemente N, Gouédard L. Anti-Müllerian hormone and its receptors. Mol Cell Endocrinol 2001;179:25-32
15. Arango NA, Lovell-Badge R, Behringer RR. Targeted mutagenesis of the endogenous mouse Mis gene promoter: In vivo definition of genetic pathways of vertebrate sexual development. Cell 1999;99:409-419
16. Tremblay JJ, Viger RS. Transcription factor GATA-4 enhances Müllerian inhibitory substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol Endocrinol 1999;13:1388-1401
17. Allard S, Adin P, Gouédard L, et al. Molecular mechanisms of hormone-related Mullerian duct regression: Involvement of β-catenin. Development 2000;127:3349-3360
18. Imbéaud S, Belville C, Messika-Zeitoun L, et al. A 27 basepair deletion of the anti-Müllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome. Hum Mol Genet 1996;5:1269-1277
19. Heyns CF, Hutson JM. Historical review of theories on testicular descent. J Urol 1995;153:754-767
20. O'Connell HE, Hutson JM, Anderson CR, Plenter RJ. Anatomical relationship between urethra and clitoris. J Urol 1998;159:1892-1897
21. Folch M, Pigem I, Konje JC. Mullerian agenesis: Etiology, diagnosis, and management. Obstet Gynecol Surv 2000;55:644-649
22. Hamerton JL. Canning N. Ray M. Smith S. A cytogenetic survey of 14,069 newborn infants: I. Incidence of chromosome abnormalities. Clin Genet 1975;8:223-243
23. Creighton SM, Minto CL, Steele SJ. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 2001;358:124-125
24. May B, Boyle M, Grant DB. A comparative study of sexual experiences: Women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Health Psychol 1996;1:479-492
25. Woodhouse CR. The sexual and reproductive consequences of congenital urinary abnormalities. J Urol 1994;152:645-651
26. Diamond M. Sigmundson HK. Management of intersexuality: Guidelines for dealing with persons with ambiguous genitalia. Arch Pediatr Adolesc Med 1997;151:1046-1050
27. Gourlay WA, Johnson HW, Pantzar JTM, et al. Gonadal tumors in disorders of sexual differentiation. Urology 1994;43:537-540
28. Slowikowska-Hilczer J, Szarras-Czapnik M, Kula K. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: An approach to pathogenesis of testis cancer. J Androl 2001;22:781-792